12/16/2024
8:50 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
12/12/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:17 PM | Atea Pharmaceuticals (Subject)
BERGER FRANKLIN M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
11:15 PM | Atea Pharmaceuticals (Filer)
| Form EFFECT | |
11/15/2024
9:34 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Atea Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/07/2024
3:41 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
11/07/2024
3:27 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:02 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:22 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:09 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
3:16 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:45 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:15 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:59 PM | Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:06 PM | Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:08 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:12 PM | Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:21 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:32 PM | Atea Pharmaceuticals (Subject)
Polsky Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
5:34 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:15 PM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
05/14/2024
3:43 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:16 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:21 PM | Atea Pharmaceuticals (Filer)
| Form DEF 14A | |
02/28/2024
3:18 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:35 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
8:15 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:02 PM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Atea Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
8:14 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
02/07/2024
8:25 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/02/2024
8:26 PM | Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:29 PM | Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:30 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:31 PM | Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:24 PM | Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:25 PM | Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:46 AM | Atea Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
Trump’s Secret Manhattan Project (Ad) On January 20, a whole new Manhattan Project is set to begin:
Trump’s Manhattan Project.
Folks, I just spent six months investigating this...and what I found is shocking. Click here and I’ll show you exactly how to position your money |
